Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Over 25% of COVID-19 patients had symptoms lasting more than a year.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

COVID-19 may harm male fertility and damage the reproductive system.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Lower Gas6 and sAxl levels are linked to hair loss in COVID-19 survivors.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Testosterone may both worsen and protect against COVID-19 effects in men.

COVID-19 doesn't make alopecia areata worse.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Timely and coordinated efforts are crucial in managing a public health crisis like COVID-19.

COVID-19 can cause various skin symptoms that usually improve with proper treatment.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

COVID-19 increases the risk of hair loss, but vaccination can reduce this risk.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

COVID-19 may cause increased and quicker hair loss compared to other infections.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.